BlackBerry price target raised to $4.60 from $4.25 at Canaccord Genuity
BlackBerry price target raised to $4.60 from $4.25 at Canaccord GenuitySource: Investing.com
Category: Investing News
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibodySource: Investing.com
H.C. Wainwright reiterates buy rating on Anixa Biosciences stock
H.C. Wainwright reiterates buy rating on Anixa Biosciences stockSource: Investing.com
Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy data
Sangamo stock holds Buy rating at H.C. Wainwright on Fabry therapy dataSource: Investing.com
Sarepta stock faces FDA scrutiny after liver failure deaths
Sarepta stock faces FDA scrutiny after liver failure deathsSource: Investing.com
H.C. Wainwright reaffirms Transcat stock rating with $116 price target
H.C. Wainwright reaffirms Transcat stock rating with $116 price targetSource: Investing.com
The Metals Company stock upgraded by Wedbush on deep sea mining boost
The Metals Company stock upgraded by Wedbush on deep sea mining boostSource: Investing.com
Nuvalent price target raised to $130 from $110 at H.C. Wainwright
Nuvalent price target raised to $130 from $110 at H.C. WainwrightSource: Investing.com
Kennedy remake of CDC vaccine panel has US insurers reassessing sources of expertise
Kennedy remake of CDC vaccine panel has US insurers reassessing sources of expertiseSource: Reuters
Worldline shares lose a quarter of their value after media reports
Worldline shares lose a quarter of their value after media reportsSource: Reuters
Contact us today to begin the process of documenting your financial transaction.
Official website:
www.taxtct.com
WhatsApp and direct call
+44 7480 219471
info@taxtct.com
جميع الحقوق محفوظة ©
All rights reserved ©